IBB ETF holdings (NASDAQ) - Page 5 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

RCUS Arcus Biosciences, Inc. 18.3 M 593.2 K 0.2%

TARS Tarsus Pharmaceuticals, Inc. 18.0 M 286.1 K 0.2%

VERA Vera Therapeutics, Inc. 17.8 M 414.5 K 0.2%

ELVN Enliven Therapeutics, Inc. 16.9 M 333.1 K 0.2%

NRIX Nurix Therapeutics, Inc. 16.9 M 695.3 K 0.2%

ALMS Alumis, Inc. 16.7 M 594.1 K 0.2%

KOD Kodiak Sciences, Inc. 16.0 M 410.5 K 0.2%

VCEL Vericel Corp. 15.9 M 358.0 K 0.2%

NTLA Intellia Therapeutics, Inc. 15.9 M 938.7 K 0.2%

CAI Caris Life Sciences, Inc. 15.5 M 869.0 K 0.2%

BCRX BioCryst Pharmaceuticals, Inc. 15.3 M 1.5 M 0.2%

AGIO Agios Pharmaceuticals, Inc. 14.7 M 395.5 K 0.2%

IRON Disc Medicine, Inc. 14.4 M 196.2 K 0.2%

SMMT Summit Therapeutics, Inc. 13.9 M 955.9 K 0.2%

AUPH Aurinia Pharmaceuticals, Inc. 13.6 M 800.9 K 0.1%

ADMA ADMA Biologics, Inc. 13.4 M 1.6 M 0.1%

BHVN Biohaven Ltd. 13.2 M 890.3 K 0.1%

ZYME Zymeworks, Inc. 13.1 M 500.6 K 0.1%

ANAB AnaptysBio, Inc. 13.1 M 193.5 K 0.1%

ABCL AbCellera Biologics, Inc. 13.0 M 1.7 M 0.1%

1
2
3
4
5
6
7
8
...
13

Notizie

UBS elenca 5 motivi chiave per cui le azioni biotech a media capitalizzazione dovrebbero performare bene nel 2026